Stock Track | Danaher Surges 5.29% Pre-market on Raised Profit Forecast and Strong Quarterly Results

Stock Track

Jul 23, 2025

Danaher Corporation (DHR) shares soared 5.29% in pre-market trading on Wednesday, following the company's announcement of raised annual profit forecasts and better-than-expected quarterly results. The life sciences firm is leveraging steady demand for bioprocessing from its pharmaceutical clients and a recovery in the Chinese market to drive growth.

The company's strong performance has caught the attention of Wall Street analysts. Jefferies reiterated a Buy rating on Danaher with a price target of $230, while Scotiabank maintained its Buy rating with a $275 price target. TD Cowen raised its target price to $250 from $248, reflecting growing confidence in the company's prospects. Baird also maintained an Outperform rating on the stock.

Analysts are particularly optimistic about Danaher's bioprocessing strength, which is expected to help the company withstand macro headwinds. J.P. Morgan, which rates Danaher as "overweight" with a $260 price target, considers it a top pick due to its strong product portfolio that is relatively shielded from macro pressures. The company's strategic focus on bioprocessing and its recovery in China are seen as key drivers for future growth, with some analysts projecting 5-6% core growth for the business in 2026 if bioprocessing demand continues to pick up.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1169608300"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169608300\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169608300?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 21:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169608300","market":"nz","top_or_hot":-1,"title":"Stock Track | Danaher Surges 5.29% Pre-market on Raised Profit Forecast and Strong Quarterly Results","media":"Stock Track","content":"<p>Danaher Corporation (DHR) shares soared 5.29% in pre-market trading on Wednesday, following the company's announcement of raised annual profit forecasts and better-than-expected quarterly results. The life sciences firm is leveraging steady demand for bioprocessing from its pharmaceutical clients and a recovery in the Chinese market to drive growth.</p>\n\n<p>The company's strong performance has caught the attention of Wall Street analysts. Jefferies reiterated a Buy rating on Danaher with a price target of $230, while Scotiabank maintained its Buy rating with a $275 price target. TD Cowen raised its target price to $250 from $248, reflecting growing confidence in the company's prospects. Baird also maintained an Outperform rating on the stock.</p>\n\n<p>Analysts are particularly optimistic about Danaher's bioprocessing strength, which is expected to help the company withstand macro headwinds. J.P. Morgan, which rates Danaher as \"overweight\" with a $260 price target, considers it a top pick due to its strong product portfolio that is relatively shielded from macro pressures. The company's strategic focus on bioprocessing and its recovery in China are seen as key drivers for future growth, with some analysts projecting 5-6% core growth for the business in 2026 if bioprocessing demand continues to pick up.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Danaher Surges 5.29% Pre-market on Raised Profit Forecast and Strong Quarterly Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Danaher Surges 5.29% Pre-market on Raised Profit Forecast and Strong Quarterly Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-07-23 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Danaher Corporation (DHR) shares soared 5.29% in pre-market trading on Wednesday, following the company's announcement of raised annual profit forecasts and better-than-expected quarterly results. The life sciences firm is leveraging steady demand for bioprocessing from its pharmaceutical clients and a recovery in the Chinese market to drive growth.</p>\n\n<p>The company's strong performance has caught the attention of Wall Street analysts. Jefferies reiterated a Buy rating on Danaher with a price target of $230, while Scotiabank maintained its Buy rating with a $275 price target. TD Cowen raised its target price to $250 from $248, reflecting growing confidence in the company's prospects. Baird also maintained an Outperform rating on the stock.</p>\n\n<p>Analysts are particularly optimistic about Danaher's bioprocessing strength, which is expected to help the company withstand macro headwinds. J.P. Morgan, which rates Danaher as \"overweight\" with a $260 price target, considers it a top pick due to its strong product portfolio that is relatively shielded from macro pressures. The company's strategic focus on bioprocessing and its recovery in China are seen as key drivers for future growth, with some analysts projecting 5-6% core growth for the business in 2026 if bioprocessing demand continues to pick up.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DHR","symbol_name":"丹纳赫","start_time":0,"source_url":"","article_id":"1169608300","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169608300","pubTimestamp":1753277466,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Danaher Corporation (DHR) shares soared 5.29% in pre-market trading on Wednesday, following the company's announcement of raised annual profit forecasts and better-than-expected quarterly results....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DHR":"丹纳赫"},"translate_title":"个股追踪|丹纳赫盘前大涨5.29%因盈利预期上调及季度业绩强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DHR":1},"content_text":"Danaher Corporation (DHR) shares soared 5.29% in pre-market trading on Wednesday, following the company's announcement of raised annual profit forecasts and better-than-expected quarterly results. The life sciences firm is leveraging steady demand for bioprocessing from its pharmaceutical clients and a recovery in the Chinese market to drive growth.\nThe company's strong performance has caught the attention of Wall Street analysts. Jefferies reiterated a Buy rating on Danaher with a price target of $230, while Scotiabank maintained its Buy rating with a $275 price target. TD Cowen raised its target price to $250 from $248, reflecting growing confidence in the company's prospects. Baird also maintained an Outperform rating on the stock.\nAnalysts are particularly optimistic about Danaher's bioprocessing strength, which is expected to help the company withstand macro headwinds. J.P. Morgan, which rates Danaher as \"overweight\" with a $260 price target, considers it a top pick due to its strong product portfolio that is relatively shielded from macro pressures. The company's strategic focus on bioprocessing and its recovery in China are seen as key drivers for future growth, with some analysts projecting 5-6% core growth for the business in 2026 if bioprocessing demand continues to pick up.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}